Circulation, Vol 64, 1212-1217, Copyright © 1981 by American Heart Association
BA Carabello, SP Nolan and LB McGuire
Twenty-one patients with symptomatic, chronic, severe mitral regurgitation
(MR) but without other valvular heart disease or coronary disease were
evaluated to determine which hemodynamic and angiographic factors might be
prognostic of surgical outcome. Sixteen patients were in New York Heart
Association functional classes I or II postoperatively and formed group A.
One patient remained in class III postoperatively and four patients died
perioperatively; they constitute group B. End-diastolic volume index (EDVI)
was less for group A than for group B, 119 +/- 25 ml/m2 vs 170 +/- 28 ml/m2
(p less than 0.001). End-systolic volume index (ESVI) was also lower in
group A, 39 +/- 19 ml/m2 vs 72 +/- 32 ml/m2 for group B (p less than 0.01).
The ratio of end-systolic wall stress to end-systolic volume index
(ESWS/ESVI) was examined in normal persons and in groups A and B. This
ratio was significantly lower in both groups than in normal persons,
indicating relatively greater end-systolic volume at a given wall stress,
suggesting left ventricular dysfunction. The ESWS/ESVI ratio in group B,
2.2 +/- 0.2, was significantly less than in group A, 3.3 +/- 0.4 (p less
than 0.001). The variables of age, pulmonary capillary wedge pressure,
EDVI, ESVI, ejection fraction and the ESWS/ESVI ratio were subjected to
stepwise discriminant multivariate analysis to determine if any were
independent predictors of outcome. The only independent predictor
determined by this method was the ESWS/ESVI ratio (p less than 0.001). We
conclude that the ESWS/ESVI ratio may be helpful in evaluating left
ventricular function and operative risk in patients with chronic,
symptomatic MR.
ARTICLES
Assessment of preoperative left ventricular function in patients with mitral regurgitation: value of the end-systolic wall stress-end- systolic volume ratio
This article has been cited by other articles:
![]() |
A. Vlahovic Stipac, P. Otasevic, Z. B. Popovic, V. Cvorovic, B. Putnikovic, I. Stankovic, and A. N. Neskovic Prognostic significance of contractile reserve assessed by dobutamine-induced changes of Tei index in patients with idiopathic dilated cardiomyopathy Eur J Echocardiogr, December 7, 2009; (2009) jep208v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. Gaasch and T. E. Meyer Left Ventricular Response to Mitral Regurgitation: Implications for Management Circulation, November 25, 2008; 118(22): 2298 - 2303. [Full Text] [PDF] |
||||
![]() |
2006 WRITING COMMITTEE MEMBERS, R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation, October 7, 2008; 118(15): e523 - e661. [Full Text] [PDF] |
||||
![]() |
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J. Am. Coll. Cardiol., September 23, 2008; 52(13): e1 - e142. [Full Text] [PDF] |
||||
![]() |
P. A. Grayburn Should we operate on asymptomatic patients with severe mitral regurgitation? J. Am. Coll. Cardiol. Img., March 1, 2008; 1(2): 142 - 144. [Full Text] [PDF] |
||||
![]() |
J. I. Fann, N. B. Ingels Jr., and D. C. Miller Pathophysiology of Mitral Valve Disease Card. Surg. Adult, January 1, 2008; 3(2008): 973 - 1012. [Full Text] |
||||
![]() |
R. Lee and T. H. Marwick Assessment of subclinical left ventricular dysfunction in asymptomatic mitral regurgitation Eur J Echocardiogr, June 1, 2007; 8(3): 175 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): e1 - e148. [Full Text] [PDF] |
||||
![]() |
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): 598 - 675. [Full Text] [PDF] |
||||
![]() |
S. G. Gordon, M. W. Miller, and A. B. Saunders Pimobendan in Heart Failure Therapy - A Silver Bullet? J. Am. Anim. Hosp. Assoc., March 1, 2006; 42(2): 90 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Detaint, D. Messika-Zeitoun, J.-F. Avierinos, C. Scott, H. Chen, J. C. Burnett Jr, and M. Enriquez-Sarano B-Type Natriuretic Peptide in Organic Mitral Regurgitation: Determinants and Impact on Outcome Circulation, May 10, 2005; 111(18): 2391 - 2397. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Mulieri, M. D. Tischler, B. J. Martin, B. J. Leavitt, F. P. Ittleman, N. R. Alpert, and M. M. LeWinter Regional differences in the force-frequency relation of human left ventricular myocardium in mitral regurgitation: implications for ventricular shape Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2185 - H2191. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Modesti, S. Vanni, I. Bertolozzi, I. Cecioni, C. Lumachi, A. M. Perna, M. Boddi, and G. F. Gensini Different Growth Factor Activation in the Right and Left Ventricles in Experimental Volume Overload Hypertension, January 1, 2004; 43(1): 101 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. I. Fann, N. B. Ingels Jr., and D. C. Miller Pathophysiology of Mitral Valve Disease Card. Surg. Adult, January 1, 2003; 2(2003): 901 - 931. [Full Text] |
||||
![]() |
B. A. Carabello Evolution of the Study of Left Ventricular Function: Everything Old Is New Again Circulation, June 11, 2002; 105(23): 2701 - 2703. [Full Text] [PDF] |
||||
![]() |
W. H. Gaasch and G. P. Aurigemma Inhibition of therenin-angiotensin systemand the left ventricularadaptation to mitral regurgitation J. Am. Coll. Cardiol., April 17, 2002; 39(8): 1380 - 1383. [Full Text] [PDF] |
||||
![]() |
K. L. Yun, C. F. Sintek, D. C. Miller, T. A. Pfeffer, G. S. Kochamba, S. Khonsari, and M. R. Zile Randomized trial comparing partial versus complete chordal-sparing mitral valve replacement: Effects on left ventricular volume and function J. Thorac. Cardiovasc. Surg., April 1, 2002; 123(4): 707 - 714. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ishibashi, J. C. Rembert, B. A. Carabello, S. Nemoto, M. Hamawaki, M. R. Zile, J. C. Greenfield Jr., and G. Cooper IV Normal myocardial function in severe right ventricular volume overload hypertrophy Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H11 - H16. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Talwar, I. B. Squire, J. E. Davies, and L. L. Ng The effect of valvular regurgitation on plasma Cardiotrophin-1 in patients with normal left ventricular systolic function Eur J Heart Fail, December 1, 2000; 2(4): 387 - 391. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Yun, C. F. Sintek, D. C. Miller, G. T. Schuyler, A. D. Fletcher, T. A. Pfeffer, G. S. Kochamba, S. Khonsari, and M. R. Zile Randomized Trial of Partial Versus Complete Chordal Preservation Methods of Mitral Valve Replacement : A Preliminary Report Circulation, November 9, 1999; 100 (2009): II-90 - II-94. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Tribouilloy, M. Enriquez-Sarano, H. V. Schaff, T. A. Orszulak, K. R. Bailey, A. J. Tajik, and R. L. Frye Impact of Preoperative Symptoms on Survival After Surgical Correction of Organic Mitral Regurgitation : Rationale for Optimizing Surgical Indications Circulation, January 26, 1999; 99(3): 400 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Ling, M. Enriquez-Sarano, J. B. Seward, T. A. Orszulak, H. V. Schaff, K. R. Bailey, A. J. Tajik, and R. L. Frye Early Surgery in Patients With Mitral Regurgitation Due to Flail Leaflets : A Long-term Outcome Study Circulation, September 16, 1997; 96(6): 1819 - 1825. [Abstract] [Full Text] |
||||
![]() |
R. B. Devereux, M. J. Roman, G. de Simone, M. J. O'Grady, M. Paranicas, J. Yeh, R. R. Fabsitz, and B. V. Howard Relations of Left Ventricular Mass to Demographic and Hemodynamic Variables in American Indians : The Strong Heart Study Circulation, September 2, 1997; 96(5): 1416 - 1423. [Abstract] [Full Text] |
||||
![]() |
B. A. Carabello and F. A. Crawford Valvular Heart Disease N. Engl. J. Med., July 3, 1997; 337(1): 32 - 41. [Full Text] [PDF] |
||||
![]() |
J. Zhang, C. Toher, M. Erhard, Y. Zhang, K. Ugurbil, R. J. Bache, T. Lange, and D. C. Homans Relationships Between Myocardial Bioenergetic and Left Ventricular Function in Hearts With Volume-Overload Hypertrophy Circulation, July 1, 1997; 96(1): 334 - 343. [Abstract] [Full Text] |
||||
![]() |
M. S. Uva, G. Dreyfus, G. Rescigno, N. A. Aile, R. Mascagni, M. La Marra, F. Pouillart, S. Pargaonkar, E. Palsky, R. Raffoul, et al. SURGICAL TREATMENT OF ASYMPTOMATIC AND MILDLY SYMPTOMATIC MITRAL REGURGITATION J. Thorac. Cardiovasc. Surg., November 1, 1996; 112(5): 1240 - 1249. [Abstract] [Full Text] |
||||
![]() |
M. R. Starling Effects of Valve Surgery on Left Ventricular Contractile Function in Patients With Long-term Mitral Regurgitation Circulation, August 15, 1995; 92(4): 811 - 818. [Abstract] [Full Text] |
||||
![]() |
Y. Okita, S. Miki, Y. Ueda, T. Tahata, T. Sakai, and K. Matsuyama Mitral valve replacement with maintenance of mitral annulopapillary muscle continuity in patients with mitral stenosis J. Thorac. Cardiovasc. Surg., July 1, 1994; 108(1): 42 - 51. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1981 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |